Want to join the conversation?
$AMGN Amgen today announced that European Commission has granted marketing authorization for Repatha (TM) (evolocumab), the first proprotein convertase subtilisin/kexin type 9 inhibitor to be approved in the world, for treatment of patients with uncontrolled cholesterol who require additional intensive low-density lipoprotein cholesterol reduction.
$PYPL jumps 6% in after hours on strong results. I am bullish on this stock.
$TSCO stock remained active in the after hours trading and rose more than 2% after the retailer posted better than expected 1Q17 results.
Instagram has reached 700 million monthly active users. Looks like it will hit 1 billion soon. That would make it $FB’s fourth billion-user platform.